As of 2026-10-05, the Relative Valuation of Aligos Therapeutics Inc (ALGS) is (252.80) USD. This relative valuation is based on P/E multiples. With the latest stock price at 5.54 USD, the upside of Aligos Therapeutics Inc based on Relative Valuation is -4663.1%.
The range of the Relative Valuation is (218.44) - (305.57) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.8x - 24.9x | 21.4x |
| Forward P/E multiples | 14.7x - 25.0x | 19.8x |
| Fair Price | (218.44) - (305.57) | (252.80) |
| Upside | -4042.9% - -5615.6% | -4663.1% |
| Date | P/E |
| 2026-10-02 | -0.45 |
| 2026-10-01 | -0.45 |
| 2026-09-30 | -0.46 |
| 2026-09-29 | -0.46 |
| 2026-09-28 | -0.45 |
| 2026-09-25 | -0.45 |
| 2026-09-24 | -0.45 |
| 2026-09-23 | -0.45 |
| 2026-09-22 | -0.46 |
| 2026-09-21 | -0.45 |
| 2026-09-18 | -0.43 |
| 2026-09-17 | -0.42 |
| 2026-09-16 | -0.41 |
| 2026-09-15 | -0.41 |
| 2026-09-14 | -0.41 |
| 2026-09-11 | -0.43 |
| 2026-09-10 | -0.43 |
| 2026-09-09 | -0.45 |
| 2026-09-08 | -0.47 |
| 2026-09-04 | -0.51 |
| 2026-09-03 | -0.51 |
| 2026-09-02 | -0.51 |
| 2026-09-01 | -0.50 |
| 2026-08-31 | -0.48 |
| 2026-08-28 | -0.56 |
| 2026-08-27 | -0.58 |
| 2026-08-26 | -0.61 |
| 2026-08-25 | -0.61 |
| 2026-08-24 | -0.56 |
| 2026-08-21 | -0.54 |
| 2026-08-20 | -0.52 |
| 2026-08-19 | -0.56 |
| 2026-08-18 | -0.55 |
| 2026-08-17 | -0.54 |
| 2026-08-14 | -0.56 |
| 2026-08-13 | -0.55 |
| 2026-08-12 | -0.57 |
| 2026-08-11 | -0.59 |
| 2026-08-10 | -0.62 |
| 2026-08-07 | -0.46 |
| 2026-08-06 | -0.45 |
| 2026-08-05 | -0.39 |
| 2026-08-04 | -0.39 |
| 2026-08-03 | -0.37 |
| 2026-07-31 | -0.34 |
| 2026-07-30 | -0.35 |
| 2026-07-29 | -0.35 |
| 2026-07-28 | -0.35 |
| 2026-07-27 | -0.33 |
| 2026-07-24 | -0.33 |